Highlights
A summary of recommended improvements for law enforcement and the justice system from the President’s Commission on Law Enforcement and the Administration of Justice.
The members were joined by more than 150 working group members, hundreds of subject matter experts, and a group of federal program managers.
Article
In the last days of the Trump administration, Attorney General William Barr released the final report on the President’s Commission on Law Enforcement and the Administration of Justice.
I’ve been in the justice system long enough to understand that the incoming administration will, in all probability, ignore the report. That would be a mistake; there are recommendations worthy of consideration.
Rahul Singhvi La Jolla, California, United States Rahul Singhvi is a global leader in the Life Sciences industry and serves as the Chief Executive Officer of National Resilience, Inc.
Most recently, Rahul was an Operating Partner at Flagship Pioneering, a Boston-based life sciences innovation firm where he was responsible for founding and operating companies launched from Flagship’s innovation foundry, Flagship labs. Before joining Flagship, Rahul was the Chief Operating Officer of Takeda’s Vaccine Business Unit where he was responsible for worldwide vaccine CMC and manufacturing operations. During his six-year tenure at Takeda, the vaccine business grew to over 500 employees and created an industry leading late-stage pipeline of vaccine candidates against dengue, norovirus, and zika. Before Takeda, Rahul was President and CEO of Novavax, Inc. (Nasdaq: NVAX) where he transformed the company from a specialty pharmaceutical business to a vaccine development com
Press release content from Business Wire. The AP news staff was not involved in its creation.
SAB Biotherapeutics Announces New Appointments to its Board of Directors
December 16, 2020 GMT
SIOUX FALLS, S.D. (BUSINESS WIRE) Dec 16, 2020
SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company developing a novel immunotherapy platform to produce specifically targeted, high potency, fully human polyclonal antibodies without the need for human serum, today announced the appointment of Mani Mohindru, PhD, and Mervyn Turner, PhD to its Board of Directors.
“We are excited to welcome Drs. Mohindru and Turner to our Board of Directors. Each industry executive brings a wealth of corporate strategy, drug development and financial expertise,” said Eddie J. Sullivan, PhD, co-founder, president and CEO of SAB Biotherapeutics. “Both Drs. Mohindru and Turner are joining SAB at a pivotal time as we continue to advance a new class of immunotherapies that leverage the native hu
SAB Biotherapeutics, Inc.: SAB Biotherapeutics Announces New Appointments to its Board of Directors
SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company developing a novel immunotherapy platform to produce specifically targeted, high potency, fully human polyclonal antibodies without the need for human serum, today announced the appointment of Mani Mohindru, PhD, and Mervyn Turner, PhD to its Board of Directors. We are excited to welcome Drs. Mohindru and Turner to our Board of Directors. Each industry executive brings a wealth of corporate strategy, drug development and financial expertise, said Eddie J. Sullivan, PhD, co-founder, president and CEO of SAB Biotherapeutics. Both Drs. Mohindru and Turner are joining SAB at a pivotal time as we continue to advance a new class of immunotherapies that leverage the native human immune response and match the evolution of human disease. We look forward to their contributions as we develop our robust pipeline, spanning
Amb. Laura Holgate to Chair the Forum’s Board Washington, DC – Today, the Stimson Center announced the launch of the
International Nuclear Security Forum (INSF) , a new project that unites a diverse group of international experts to identify, create, and support strategies for reducing nuclear terrorism risks. The Forum aims to be the leading space for the nuclear security community to collaborate and share expertise, educate stakeholders, support international nuclear security implementation and architecture, promote information sharing, and foster international leadership. It builds on the achievements of the Fissile Materials Working Group (FMWG), the preeminent civil society coalition that supported policies to reduce the risk of nuclear terrorism until earlier this year.